These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 26409030)
1. Effects of buprenorphine on responses to social stimuli in healthy adults. Bershad AK; Seiden JA; de Wit H Psychoneuroendocrinology; 2016 Jan; 63():43-9. PubMed ID: 26409030 [TBL] [Abstract][Full Text] [Related]
2. Effects of Buprenorphine on Responses to Emotional Stimuli in Individuals with a Range of Mood Symptomatology. Bershad AK; Ruiz NA; de Wit H Int J Neuropsychopharmacol; 2018 Feb; 21(2):120-127. PubMed ID: 29025085 [TBL] [Abstract][Full Text] [Related]
3. Naltrexone alters the processing of social and emotional stimuli in healthy adults. Wardle MC; Bershad AK; de Wit H Soc Neurosci; 2016 Dec; 11(6):579-91. PubMed ID: 26710657 [TBL] [Abstract][Full Text] [Related]
4. Morphine reduced perceived anger from neutral and implicit emotional expressions. Løseth GE; Eikemo M; Isager P; Holmgren J; Laeng B; Vindenes V; Hjørnevik T; Leknes S Psychoneuroendocrinology; 2018 May; 91():123-131. PubMed ID: 29550675 [TBL] [Abstract][Full Text] [Related]
5. Improved memory for reward cues following acute buprenorphine administration in humans. Syal S; Ipser J; Terburg D; Solms M; Panksepp J; Malcolm-Smith S; Bos PA; Montoya ER; Stein DJ; van Honk J Psychoneuroendocrinology; 2015 Mar; 53():10-5. PubMed ID: 25569708 [TBL] [Abstract][Full Text] [Related]
6. Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans. Bershad AK; Jaffe JH; Childs E; de Wit H Psychoneuroendocrinology; 2015 Feb; 52():281-8. PubMed ID: 25544740 [TBL] [Abstract][Full Text] [Related]
7. Reduced fear-recognition sensitivity following acute buprenorphine administration in healthy volunteers. Ipser JC; Terburg D; Syal S; Phillips N; Solms M; Panksepp J; Malcolm-Smith S; Thomas K; Stein DJ; van Honk J Psychoneuroendocrinology; 2013 Jan; 38(1):166-70. PubMed ID: 22651957 [TBL] [Abstract][Full Text] [Related]
8. Effects of MDMA on sociability and neural response to social threat and social reward. Bedi G; Phan KL; Angstadt M; de Wit H Psychopharmacology (Berl); 2009 Nov; 207(1):73-83. PubMed ID: 19680634 [TBL] [Abstract][Full Text] [Related]
9. Effects of opioid- and non-opioid analgesics on responses to psychosocial stress in humans. Bershad AK; Miller MA; Norman GJ; de Wit H Horm Behav; 2018 Jun; 102():41-47. PubMed ID: 29673620 [TBL] [Abstract][Full Text] [Related]
10. Oxytocin reduces top-down control of attention by increasing bottom-up attention allocation to social but not non-social stimuli - A randomized controlled trial. Xu X; Li J; Chen Z; Kendrick KM; Becker B Psychoneuroendocrinology; 2019 Oct; 108():62-69. PubMed ID: 31229634 [TBL] [Abstract][Full Text] [Related]
11. The effects of buprenorphine on fentanyl withdrawal in rats. Bruijnzeel AW; Marcinkiewcz C; Isaac S; Booth MM; Dennis DM; Gold MS Psychopharmacology (Berl); 2007 May; 191(4):931-41. PubMed ID: 17211652 [TBL] [Abstract][Full Text] [Related]
12. Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder. Nasser AF; Greenwald MK; Vince B; Fudala PJ; Twumasi-Ankrah P; Liu Y; Jones JP; Heidbreder C J Clin Psychopharmacol; 2016 Feb; 36(1):18-26. PubMed ID: 26650971 [TBL] [Abstract][Full Text] [Related]
13. The µ-opioid system promotes visual attention to faces and eyes. Chelnokova O; Laeng B; Løseth G; Eikemo M; Willoch F; Leknes S Soc Cogn Affect Neurosci; 2016 Dec; 11(12):1902-1909. PubMed ID: 27531386 [TBL] [Abstract][Full Text] [Related]
14. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice. Ide S; Minami M; Satoh M; Uhl GR; Sora I; Ikeda K Neuropsychopharmacology; 2004 Sep; 29(9):1656-63. PubMed ID: 15100703 [TBL] [Abstract][Full Text] [Related]
15. Naltrexone increases negatively-valenced facial responses to happy faces in female participants. Meier IM; Bos PA; Hamilton K; Stein DJ; van Honk J; Malcolm-Smith S Psychoneuroendocrinology; 2016 Dec; 74():65-68. PubMed ID: 27588701 [TBL] [Abstract][Full Text] [Related]
16. Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior. Wardle MC; Garner MJ; Munafò MR; de Wit H Psychopharmacology (Berl); 2012 Sep; 223(2):199-210. PubMed ID: 22526538 [TBL] [Abstract][Full Text] [Related]
17. The administration of the opioid buprenorphine decreases motivational error signals. Pfabigan DM; Rütgen M; Kroll SL; Riečanský I; Lamm C Psychoneuroendocrinology; 2021 Jun; 128():105199. PubMed ID: 33933894 [TBL] [Abstract][Full Text] [Related]
18. Effects of MDMA on attention to positive social cues and pleasantness of affective touch. Bershad AK; Mayo LM; Van Hedger K; McGlone F; Walker SC; de Wit H Neuropsychopharmacology; 2019 Sep; 44(10):1698-1705. PubMed ID: 31042696 [TBL] [Abstract][Full Text] [Related]
19. Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine. Upadhyay J; Anderson J; Baumgartner R; Coimbra A; Schwarz AJ; Pendse G; Wallin D; Nutile L; Bishop J; George E; Elman I; Sunkaraneni S; Maier G; Iyengar S; Evelhoch JL; Bleakman D; Hargreaves R; Becerra L; Borsook D Neuroimage; 2012 Feb; 59(4):3762-73. PubMed ID: 22119647 [TBL] [Abstract][Full Text] [Related]
20. A role for the mu opioid receptor in the antidepressant effects of buprenorphine. Robinson SA; Erickson RL; Browne CA; Lucki I Behav Brain Res; 2017 Feb; 319():96-103. PubMed ID: 27818236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]